Oskar Johannsson
Overview
Explore the profile of Oskar Johannsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
266
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bancroft E, Page E, Brook M, Thomas S, Taylor N, Pope J, et al.
Lancet Oncol
. 2021 Oct;
22(11):1618-1631.
PMID: 34678156
Background: Lynch syndrome is a rare familial cancer syndrome caused by pathogenic variants in the mismatch repair genes MLH1, MSH2, MSH6, or PMS2, that cause predisposition to various cancers, predominantly...
2.
Page E, Bancroft E, Brook M, Assel M, Hassan Al Battat M, Thomas S, et al.
Eur Urol
. 2019 Sep;
76(6):831-842.
PMID: 31537406
Background: Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-antigen (PSA) in men with germline BRCA1/2...
3.
Mikropoulos C, Hutten Selkirk C, Saya S, Bancroft E, Vertosick E, Dadaev T, et al.
Br J Cancer
. 2018 Mar;
118(6):e17.
PMID: 29509747
This corrects the article DOI: 10.1038/bjc.2017.429.
4.
Mikropoulos C, Hutten Selkirk C, Saya S, Bancroft E, Vertosick E, Dadaev T, et al.
Br J Cancer
. 2018 Jan;
118(2):266-276.
PMID: 29301143
Background: Prostate-specific antigen (PSA) and PSA-velocity (PSAV) have been used to identify men at risk of prostate cancer (PrCa). The IMPACT study is evaluating PSA screening in men with a...
5.
Bancroft E, Page E, Castro E, Lilja H, Vickers A, Sjoberg D, et al.
Eur Urol
. 2014 Feb;
66(3):489-99.
PMID: 24484606
Background: Men with germline breast cancer 1, early onset (BRCA1) or breast cancer 2, early onset (BRCA2) gene mutations have a higher risk of developing prostate cancer (PCa) than noncarriers....
6.
Cox D, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, et al.
Hum Mol Genet
. 2011 Sep;
20(23):4732-47.
PMID: 21890493
Mutations in the BRCA1 gene substantially increase a woman's lifetime risk of breast cancer. However, there is great variation in this increase in risk with several genetic and non-genetic modifiers...
7.
Ingthorsson S, Halldorsson T, Sigurdsson V, Fridriksdottir A, Bodvarsdottir S, Steinarsdottir M, et al.
In Vitro Cell Dev Biol Anim
. 2010 Nov;
47(2):139-48.
PMID: 21082277
An epithelial cell line, referred to as A163, was established from breast carcinoma derived from a patient with a strong family history of breast cancer but no known breast cancer...
8.
Nilbert M, Kristoffersson U, Ericsson M, Johannsson O, Rambech E, Mangell P
BMC Med Genet
. 2008 Nov;
9:101.
PMID: 19036155
Background: Familial adenomatous polyposis (FAP) is typically characterized by multiple colonic polyps and frequent extracolonic features. Whereas the number of colonic polyps has been linked to the APC gene mutation,...
9.
Adeyinka A, Baldetorp B, Mertens F, Olsson H, Johannsson O, Heim S, et al.
Cancer Genet Cytogenet
. 2003 Oct;
147(1):62-7.
PMID: 14580772
The cytogenetic and DNA flow cytometric findings in 242 breast carcinomas were compared. The combined use of both techniques improved the detection of abnormal cell populations from 65% by cytogenetic...
10.
Loman N, Bladstrom A, Johannsson O, Borg A, Olsson H
Breast Cancer Res
. 2003 Oct;
5(6):R175-86.
PMID: 14580253
Background: Relatives of breast cancer cases have an increased risk of the disease. The risk increases with increasing numbers and decreasing age of onset of affected relatives. In families with...